New drug cocktail shows promise against tonsil cancer
NCT ID NCT07353723
First seen Jan 23, 2026 · Last updated May 01, 2026 · Updated 18 times
Summary
This study tests whether giving a combination of three drugs (nimotuzumab, toripalimab, and chemotherapy) before surgery can shrink advanced tonsil cancer and improve outcomes. Ten adults with resectable tonsil cancer will receive the treatment and then have surgery. The main goal is to see if the cancer disappears completely after the drug combo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD & NECK CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tangdu Hospital, Air Force Medical University, Xi'an 710038, Shaanxi Province, China
RECRUITINGShanxi, Province, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.